71 related articles for article (PubMed ID: 11310794)
1. Aberrant expression of MSG1 transcriptional activator in human malignant melanoma in vivo.
Ahmed NU; Shioda T; Coser KR; Ichihashi M; Ueda M
Pigment Cell Res; 2001 Apr; 14(2):140-3. PubMed ID: 11310794
[TBL] [Abstract][Full Text] [Related]
2. Regulation of expression of MSG1 melanocyte-specific nuclear protein in human melanocytes and melanoma cells.
Li H; Ahmed NU; Fenner MH; Ueda M; Isselbacher KJ; Shioda T
Exp Cell Res; 1998 Aug; 242(2):478-86. PubMed ID: 9683535
[TBL] [Abstract][Full Text] [Related]
3. msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation.
Shioda T; Fenner MH; Isselbacher KJ
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12298-303. PubMed ID: 8901575
[TBL] [Abstract][Full Text] [Related]
4. MSG1 (melanocyte-specific gene 1): mapping to chromosome Xq13.1, genomic organization, and promoter analysis.
Fenner MH; Parrish JE; Boyd Y; Reed V; MacDonald M; Nelson DL; Isselbacher KJ; Shioda T
Genomics; 1998 Aug; 51(3):401-7. PubMed ID: 9721210
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of MSG1 transcriptional co-activator increases melanin in B16 melanoma cells: a possible role for MSG1 in melanogenesis.
Nair SS; Chaubal VA; Shioda T; Coser KR; Mojamdar M
Pigment Cell Res; 2001 Jun; 14(3):206-9. PubMed ID: 11434569
[TBL] [Abstract][Full Text] [Related]
6. Expression of thyrotropin-releasing hormone by human melanoma and nevi.
Ellerhorst JA; Naderi AA; Johnson MK; Pelletier P; Prieto VG; Diwan AH; Johnson MM; Gunn DC; Yekell S; Grimm EA
Clin Cancer Res; 2004 Aug; 10(16):5531-6. PubMed ID: 15328193
[TBL] [Abstract][Full Text] [Related]
7. MSG1 and its related protein MRG1 share a transcription activating domain.
Shioda T; Fenner MH; Isselbacher KJ
Gene; 1997 Dec; 204(1-2):235-41. PubMed ID: 9434189
[TBL] [Abstract][Full Text] [Related]
8. Melanocyte-specific gene 1 promotes melanoma progression by enhancing the expression of Bcl-2.
Zhao H; Wu G; Zhu J; Sun M; Wang Y; Fan Y; Wu K; Bi H; Dai H; Lv C; Xue C
Oncol Lett; 2018 Feb; 15(2):2413-2418. PubMed ID: 29434952
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.
Bordoni R; Fine R; Murray D; Richmond A
J Cell Biochem; 1990 Dec; 44(4):207-19. PubMed ID: 2095366
[TBL] [Abstract][Full Text] [Related]
10. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
11. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
[TBL] [Abstract][Full Text] [Related]
12. Wilms tumor 1 expression present in most melanomas but nearly absent in nevi.
Perry BN; Cohen C; Govindarajan B; Cotsonis G; Arbiser JL
Arch Dermatol; 2006 Aug; 142(8):1031-4. PubMed ID: 16924053
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
14. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.
Behrmann I; Wallner S; Komyod W; Heinrich PC; Schuierer M; Buettner R; Bosserhoff AK
Am J Pathol; 2003 Aug; 163(2):683-90. PubMed ID: 12875987
[TBL] [Abstract][Full Text] [Related]
15. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
[TBL] [Abstract][Full Text] [Related]
16. Dynamic gene expression analysis links melanocyte growth arrest with nevogenesis.
Yang G; Thieu K; Tsai KY; Piris A; Udayakumar D; Njauw CN; Ramoni MF; Tsao H
Cancer Res; 2009 Dec; 69(23):9029-37. PubMed ID: 19903842
[TBL] [Abstract][Full Text] [Related]
17. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
